Trump’s Pick SUNK — And Look Who Launched The TORPEDO

Hands reaching above water in open sea
Photo: New Africa / Shutterstock

The White House pulled Heidi Overton’s nomination to lead the Food and Drug Administration, because she lacked the Republican votes to win confirmation, a senior administration official said.

Story Highlights

  • The White House dropped Overton’s nomination as FDA commissioner on Tuesday, November 17, a day before a Senate committee vote
  • A senior administration official said she lacked the support on Capitol Hill to move forward
  • Committee chair Bill Cassidy had called her ties to efforts to cut childhood vaccine use “almost disqualifying”
  • The White House has talked with other possible candidates, some who could serve as acting commissioner without a Senate vote

The Nomination Is Pulled

On Tuesday, November 17, the White House dropped Dr. Heidi Overton, President Trump’s pick for FDA commissioner, according to a senior administration official and others familiar with the decision. The Senate health committee had been set to vote on her on Wednesday, November 18. The official said she “lacks the support on the Hill to move forward with her confirmation.” Overton had served on the White House Domestic Policy Council and stood beside Trump when he signed an executive order on vaccines this summer. The reports included no public comment from Overton, and the White House did not immediately respond to a request for comment.

The committee is known as the HELP Committee, short for Health, Education, Labor and Pensions. It held her confirmation hearing on September 24. The nomination was pulled before any vote, so there is no committee tally.

Why She Lacked the Votes

Sen. Bill Cassidy, the Louisiana Republican and doctor who chairs the committee, had said her ties to efforts to reduce childhood vaccine use were “almost disqualifying.” He told reporters he was still working the phones and had not said how he would vote. No Democrats were expected to back her, which meant she could afford few Republican defections.

Sen. Josh Hawley, a Republican, had questioned her answers on mifepristone, an abortion drug. Sens. Susan Collins and Lisa Murkowski had not said whether they would vote to advance her. Cassidy also worried that an acting commissioner, who needs no Senate vote, would be more influenced by the health secretary, Robert F. Kennedy Jr.

Who Could Be Next

The White House has talked with possible replacements, including some who could serve as acting commissioner without Senate confirmation. Two sources said Sen. Roger Marshall of Kansas, who lost his reelection bid earlier this month, is pursuing the job. Kyle Diamantas is the acting commissioner and leads the FDA. The White House has not released a formal withdrawal letter.

Sources:

cbsnews.com, cbsnews.com, cbs12.com, usnews.com, axios.com